Thursday, October 31, 2019

Diabetes Drugs Market: Global Market Revenue and Share by Manufacturers

According to projections from the TMR analysts, the global diabetes drugs market is prognosticated to exhibit a healthy 3.6% CAGR between the forecast duration 2017 to 2025. At this rate, the market is predicted to be worth US$58.4 bn by 2025, rising from an estimated US$43.1 bn in 2016.
The Type 2 diabetes segment accounts for important sales of the global diabetes drug market among the distinct kinds. The high incidence of type 2, owing to sedentary lifestyles and obesity in all age groups is attributed to this situation. Geographically speaking, North America dominates the worldwide market for diabetes drugs because of unhealthy nutritional habits that lead to the region’s elevated incidence of diabetes.
Get PDF Brochure for Research Insights at 
Changing Lifestyle to Trigger Diabetes Drugs Market
The increased revenue per capita is leading to a sedentary lifestyle, in turn leading to a high incidence of obesity, a major cause of diabetes. The growing inclination to physical inactivity increases diabetes incidence and the demand for diabetes drugs in turn increases. This is due to the increase in the diabetes market in medicines. Diabetes drug markets are driven by the increasing incidence of diabetes in both advanced and developed countries. WHO reports that 422 million individuals worldwide suffered from diabetes. WHO has also indicated that 1.5 million individuals died from diabetes in 2012, boosting market growth during the forecast period. The rising incidence of diabetes is fuelling the demand in the global diabetes drug market to a large extent.
Request a Sample of Report at
Novel Industry Developments Boost Diabetes Drug Market
The demand for diabetes medicines led to significant research and development progress, including in 2017, the US healthcare firm Novo Nordisk A / S, with more than 90 years of diabetes innovation, introduced Xultophy, (an insulin degludec and liraglutide mixture) as a supplement to exercise and diet to enhance the type 2 diabetes mellitus glycemic control in adolescents. The WHO reports that 422 million individuals around the globe suffer from diabetes.
Patent expiry and exclusivity of drugs can however, during the forecast period, restrict the market of branded medicines. The existence of a robust product pipeline further fuels the global diabetes drug market.
Request for Discount on this Report –
Personalized Medicine to Emerge as Key Market Trend
The growing use of personalized medicines is a significant trend anticipated to develop traction patterns in the diabetes drug market. Custom medicine is an evolving idea for treating illnesses, which includes specific information on a certain patient and then a therapy for the patient. A personalized medicine strategy to diabetes is likely to benefit from previous measures to avoid or treat disease using genetic screening tests. In the next few years, this trend could boost the augur well for the development of the global diabetes drug market.
The global diabetes drug market is projected to experience a healthy growth forthcoming years, according to a Transparency Market Research (TMR) study.  The global market for diabetes drugs is presently fragmented with a large pool of market suppliers, which fosters palpable competition.
Request For Custom Research –
In future the rivalry in the diabetes drug market is anticipated to amplify, with vendors’ growing intent on capturing market shares. The focus is on the presentation of an innovative product. For instance, in association with JRDF, Biocon India recently developed the world’s first oral insulin. The established participants adopt policies such as the development of strategic alliances, and mergers and acquisition to gain traction in the global diabetes drug market. Prominent players in the global diabetes drug market are Boehringer Ingelheim GmbH, Sanofi, Bayer AG, Novo Nordisk A/S, and Merck & Co.
Posted by at No comments:

Shock Wave Therapy Device Market Report Explored in Latest Research 2017 - 2025

Transparency Market Research (TMR) has published a new report titled “Shock Wave Therapy Device Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017-2025”. According to the report the global shock wave therapy device market was valued at US$ 91.6 Mn in 2016 and is projected to expand at a CAGR of 5.0% from 2017 to 2025. The report suggests that increase in number of bone injuries and rise in demand for chair time optimization is projected to boost the shock wave therapy device market during the forecast period (2017 to 2025). North America and Europe are projected to dominate the global market owing to increase in adoption of shock wave therapy device for treatment by orthopedic doctors and patients. The market in Asia Pacific is projected to expand at exponential CAGR during the forecast period. Growth of market in Asia Pacific is attributed to large number of private clinics and hospitals, rise in the number of geriatric population requiring physiotherapy services after bone surgery, and increase in adoption of sports activities among the youth. The market for shock wave therapy device in Latin America is likely to expand at moderate growth rate during the forecast period.
Get PDF Brochure for Research Insights at
Value Added Features in Shock Wave Therapy Device to Fuel Global Market Expansion
The global shock wave therapy device market is projected to be driven by value added features offered by various shock wave therapy device companies to streamline the day-to-day work flow and increase revenue of practices. The shock wave therapy device provides a wide range of features and benefits from patient pain healing remedies to treatment procedures at varied frequencies. These features help physicians and nurse to streamline physiotherapy activities required for the patients to maintain their daily routine efficiently and effectively. Key players offering shock wave therapy devices are coming up with value added features such as effective probes, sensors, ultrasound devices, laser connectivity, effective modality features, and imaging modules, thereby reducing the overall operating cost and improving the effectiveness and efficiency of physiotherapy. These companies are focusing on developing combined shock wave therapy facilities in their system to effectively integrate therapy or treatment procedure along with imaging tools such as cameras, digital radio-graphs, high sensors, and patient education & awareness programs. These value added features save operational time of physicians and help improve pain management performance.
Radial or Ballistic Shock Wave Generation is Projected to be a Highly Lucrative Deployment Mode
Focused shock wave generation based technology is commonly used in the pain management therapy. This technology is associated with electromagnetic, electrohydraulic, and piezoelectric methodology. Price of this technology is based on perpetual license model. The radial or ballistic shock wave generation technology enables the usage of shock wave therapy device in low frequency clinical applications. This allows healing of extreme pain in musculoskeletal structures and assures 90% recovery. These attributes are likely to propel the segment during forecast period. Radial or ballistic shock wave generation based technology addresses specific challenges faced during the treatment procedure due to its low frequency shock wave therapy. The radial or ballistic shock wave generation technology provides pain relief, increase in range of motion and muscular strength in patients who have undergone bone injury.
Orthopedic and Urology Application of Shock Wave Therapy Device Leads the Market
The report offers detailed segmentation about applications of shock wave therapy device into orthopedic, cardiology, erectile dysfunction and urology. The orthopedic and urology segment is expected to account for a leading share of the market during the forecast period (2017-2025). High share of the orthopedic and urology segments are attributed to rise in orthopedic surgeries, prevalence of kidney stones among global population, and increase in demand for lithotripsy by physicians and patients contribute to the high market share of the orthopedic and urology segments. Furthermore, availability of various reimbursement and Medicare benefits for patients for the treatment of diseases is projected to propel the orthopedic & urology segments.
Request Sample of Report:
Hospitals Segment to Dominate the Market During the Forecast Period
The hospitals segment accounted for a leading share of the global shock wave therapy device market. It is estimated to gain market share by the end of 2025. The segment is expected to expand at a CAGR of more than 5% during the forecast period. Expansion of the specialized pain management service, increase in number of orthopedic patient footfall in hospitals, and adoption of digital platforms for marketing pain management practices has contributed to the dominant share of the segment. Increase in number of multinational hospital chains and high digitization budgets are likely to drive the hospitals segment during the forecast period. High prevalence and incidence rates of bone injuries and kidney stones and increase in number of cases of erectile dysfunction across the global has increased patient flow to clinics. These factors are expected to fuel the clinic segment between 2017 and 2025.
Asia Pacific to Create Business Development Opportunities
North America and Europe accounted for a major share of the global shock wave therapy device market in 2016 and are likely to gain their share by 2025. High adoption of digital platforms for pain management, rise in health care budgets, and government initiative to promote minimally invasive surgery techniques have contributed to the dominant market share of these regions. Asia Pacific is projected to be the most lucrative market, with highest attractiveness index. The market in the Asia Pacific region is projected to expand at a CAGR of over 6% during the forecast period. Expansion of the market in the region is due to large number of clinics in emerging countries such as India and China, well established health care facilities and high adoption of digital health care technology in countries such as Japan, Australia & New Zealand, Malaysia, and Singapore. Market in Latin America is anticipated to expand at a moderate growth rate during the forecast period.
Key trend of research and development among the leading Players to Increase Geographic Presence has been observed in last few years.
The report also provides profiles of leading players operating in the global shock wave therapy device market. EMS Electro Medical Systems S.A., BTL Corporate, Dornier MedTech GmbH, and Zimmer MedizinSysteme GmbH are some leading players operating in the global shock wave therapy device market. These companies are engaged in increasing their geographic presence through strategic acquisition and collaboration with other leading players. In October 2017, Dynatronics Corporation partnered with Zimmer MedizinSysteme GmbH (Zimmer) for exclusive distribution of select therapy equipment in the U.S. Other prominent players operating in the global shock wave therapy device include Siemens AG, Boston Scientific Corporation, ?NCELER MEDICAL LTD, and Guangzhou Longest Science & Technology Co.
Posted by at No comments:

Pulmonary Arterial Hypertension (PAH) Market: Insights and Emerging Trends by 2020

According to TMR, the global pulmonary arterial hypertension therapeutics market is expected to reach a valuation of US$ 5.19 bn by the end of 2020. The global pulmonary arterial hypertension market is segmented based on drug class, which includes PDE-5 inhibitors, prostacyclin and prostacyclin analogs, endothelin receptor antagonists (ERAs), soluble guanylate cyclase (sGC) stimulators and selexipag. Among these, prostacyclin and prostacyclin analogs are estimated to outgrow PAH market by the end forecast period. Geographically, North America is leading the global PAH market followed by Europe. Increasing awareness among the people for better availability of treatment for pulmonary arterial hypertension therapeutics has further fueled the market.
Request to View Sample of Report – 
Launch of Innovative Treatment Therapies to Boost the Pulmonary Arterial Hypertension Therapeutic Market
Pulmonary hypertension occurs due to high blood pressure in arteries caused by shortness of breath, chest pain, fast heartbeat, tiredness, and syncope. By the help of certain treatments, it is possible to curb the progression of the disease, control its symptoms, and improve quality of life, thus increasing the demand for pulmonary arterial hypertension. The market is expected to gain impetus from the approval of new and effective drugs and the presence of effective regulatory measures. In addition, promising government initiatives and changing traditional norms are going to enhance and grow the development of the market. Moreover, innovative therapies used for treatments will accentuate growth for pulmonary arterial hypertension therapeutic market in the coming years.
Unsuccessful Clinical Trials and Slow Process in Drug Research and Development to Hamper Growth
The presence of generic medicines that are cost effective with the same proportion to medication can restrict the market. Excessive use of tobacco, smoking, high consumption of alcohol and idiopathic conditions have increased health risks in past few years. Furthermore, due to slow growth of research and development, that has increased cost of treatments and diagnosis, faulty drugs identified during clinical trials, and lack of awareness about pulmonary arterial hypertension will obstruct the growth of this market. Nonetheless, the pulmonary arterial hypertension therapeutic market is expected to overcome the limitations that will boost the market substantially during the forecast period.
Request PDF Brochure of Report: 
A recent report by Transparency Market Research (TMR) on the global pulmonary arterial hypertension therapeutics market states that there is a huge amount of opportunity for the market to grow in the coming years. As there is no permanent treatment for pulmonary arterial hypertension (PAH) the market is expected to expand considerably by the end of 2020. Government initiatives in promoting research and development of orphan drugs has boosted the market for PAH. Approved certified agents producing therapeutics drugs will significantly grow the market in coming years. Some of the prominent players in the global market for pulmonary arterial hypertension are United Therapeutics Corp, Gilead Sciences Inc., GlaxoSmithKline Plc., Bayer HealthCare, Actelion Pharmaceuticals Ltd., and Novartis International AG, Pfizer Inc.
The information presented in this review is based on a TMR report, titled “Pulmonary Arterial Hypertension (PAH) Market (Drug Class – Prostacyclin and Prostacyclin Analogs, ERAs, PDE-5 Inhibitors, and sGC Stimulators; Pipeline Stage – Early-stage Drug Candidates (Phase I & Phase II) and Late-stage Drug Candidates (Phase III & Registration Phase)) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020.”
Posted by at No comments:

Collagen Market Trends and Growth Factors Analysis 2015 - 2023

TMR’s report based on the global collagen market predicted the growth at a CAGR of 9.4% over the forecast period from 2015 to 2023. With the vigorous CAGR, the market is expected to attain a value of US$9.37 bn by 2023 from a value of US$4.13 bn in 2014.
Based on the source, the bovine collagen segment dominated by registering the consumption of 30-kilo tons of collagen in the overall market in the year 2014. Additionally, the porcine collagen segment accounted for 27.4-kilo tons of global consumption in the collagen market in the same year. However, the market for marine collagen segment is expected to expand at the highest CAGR of 11.6% from 2015 to 2023 in terms of volume. Based on the region, North America and Europe collectively accounted for a 60% share in the global collagen market in 2014. This is attributable to the high awareness about the numerous benefits of these products in the region.
Widening Applications of Collagen-based Products to Propel Market’s Growth
The global collagen market is witnessing growth on the back of vast applications of the collagen, especially across the food and beverages industry along with healthcare and pharmaceuticals. Additionally, collagen-based products offer superior properties than normal products such as gelling, improved binding, and improved emulsification properties. High demand for products with these improved properties is likely to drive growth of the global collagen is market.
Moreover, collagen has a key application during manufacturing gelatin; thus, the demand for gelatin mainly in the production of jellies, desserts, and chewing gums is growing substantially. This demand is a key factor propelling growth of the collagen market. Additionally, demand for the hydrolyzed collagen is expected to increase from healthcare industry mainly due to high adoption of the tissue engineering and bone grafting. Additionally, rising incidences of dental surgeries coupled with the use of high-quality collagen in cosmetic surgeries are propelling growth of the global collagen market. Rising incidences of the anti-aging treatments and rejuvenating ingredients are expected to fuel growth of the global collagen market in the coming years.
Extensive Applications of the Collagen-based Products in Healthcare to Boost Growth
The need for collagen supplements coupled with enhanced use of the collagen mainly in the drug delivery system and medical devices supporting growth of the market. In addition, effectiveness of collagen for wound healing and adaptability for minimally invasive operating techniques are driving growth of the collagen market. Moreover, collagen-based products are used in the treatments of the cardiovascular diseases and obesity cases; rising obese population globally is driving growth of the global collagen market. Furthermore, it has widened applications across the strengthen nails and teeth, heal leaky gut, reduce joint pains and degeneration, protect against cardiovascular disorders, and improve liver health are offering opportunities for growth in the global collagen market in the coming years.
Request a Sample of Report at
The global collagen market is highly fragmented, Transparency Market Research (TMR) examined during their detailed study. The presence of numerous small and local players in the market has led to an increase in the fragmentation of the market. Collagen Solutions plc, Kyeron B.V., Medtronic plc, Nippi, Inc., botiss biomaterials GmbH, and Collagen Matrix, Inc are dominating the global collagen market. Additionally, new entrants and small players are emerging as a tough competition to well-established market players as they offer products at competitive prices.
Posted by at No comments:

Wound Healing Market Current Trends and Future Aspect Analysis 2017 - 2025

The global Wound Healing market was valued at approximately US$ 23.3 Bn in 2016 is projected to register cumulative annual growth rate (CAGR) of over 4.8% from 2017 to 2025, according to a new report published by Transparency Market Research titled “Wound Healing Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017-2025″. The report suggests that increasing patient pool for chronic wounds is likely to spur the demand of wound healing products in the coming years (2017 to 2025). As key players introduce technologically advanced wound healing solutions in developed markets such a North America and Europe, these regions are likely to account for dominating share of the global wound healing market. Established presence & wide distribution networks of major players and growing market penetration of emerging players are likely to boost growth of Asia Pacific wound healing market at a CAGR of around 5.3% from 2017 to 2025.
Get PDF Brochure for Research Insights at
Chronic Wounds to Be the Most Promising Wound Type to Invest In
Among wound types, chronic wounds segment is projected to hold dominant share of global wound healing market during the forecast period and is likely to expand at CAGR of around 5.0% from 2017 to 2025. From chronic wounds, ulcers sub-segment is expected to lead the global wound healing market in terms of CAGR by 2025. As per the Agency for Healthcare Research & Quality (AHRQ), in U.S. US$ 9.0 Bn to US$ 11.0 Bn are spent on pressure ulcers by health care systems annually. Significant patient population, and availability of favorable reimbursement policies which are driving manufacturers’ focus on business expansion in advanced wound care products are projected to fuel this expansion. Significant economic burden of surgical site infections (SSI), and higher treatment costs associated with it is expected to propel the expansion of chronic wound segment during 2017-2025.
Women are to Capture Relatively Significant Market Share during the Forecast Period
In case of women, especially in low and middle income countries, there is significant gap between reported and actual cases of diabetes and chronic wounds, which is anticipated to improve during forecast period. In terms of gender, women segment held 52.9% of global wound healing market share in terms of revenue. Initiatives such as Wound Awareness Week and other outreach programs are projected to increase the awareness in significant patient population.
Asia Pacific to Register Exponential Growth Rate and Offer Huge Incremental Opportunity
In terms of value, North America was leading contributor in global wound healing market in 2016. As per the data published by ‘Wound Care Awareness Week-2017’, the annual cost (including direct as well as indirect costs) of treatment of all types of wounds incurred to health care systems in the U.S. is US$ 50.0 Bn, while the annual cost of amputations exceeds US$ 8.0 Bn. High prevalence of chronic wound in this region is imposing significant economic burden and is increasing demand for affordable care in the U.S., which in turn is driving the growth of wound healing market in North America. Healthcare spending in emerging markets such as China and India are rising, which is fueling the expansion of Asia Pacific wound healing market. Geographical expansion of international players to this region through distribution and licensing agreements with local distributors in the region are anticipated to propel the growth of Asia Pacific in global wound healing market at CAGR of 5.3% from 2017 to 2025. Regaining economic growth in Latin America countries such as Brazil is augmenting healthcare expenditure through rise in private health insurance, entry of international wound healing products manufacturers & health care providers in this region. It is one of the major factor for the estimated growth of Latin America during 2017-2025.
Request For Discount On This Report:
High Cost of Advanced Wound Care Products to Restrain Global Market Expansion
According to the Centers of Disease Control (CDC) statistics, an estimated 450,000 – 500,000 patients suffer from burn injuries each year in the U.S. The direct costs of treatment of burn injuries in the U.S., was estimated to be around US$ 10.4 Bn. Wounds impose underappreciated burden on the population across the globe and they account for the majority of injuries related to skin. Rise in the prevalence of diabetes and obesity, and increasing adoption rate for wound care therapy devices in developed and emerging markets are likely to fuel the uptake of wound healing products by 2025. However, high price of newly launched and technologically advanced wound care products restricts their demand. Conventional wound healing products are preferred over technologically advanced costly dressings in the emerging economies, despite their slow healing process. The price sensitive market of developing nations thus restricts the growth of advanced wound management technologies, which in turn has attributed for devaluation of the market, thereby restraining growth of global wound healing market.
Wound Closure Agents to Lose Market Share
The report offers detailed segmentation of global Wound Healing market based on product, wound type, and gender. Among the product types studied, wound closure agents segment is poised to account for leading share of the global market during the forecast period from 2017 to 2025. Topical agents segment which comprises hemostatic agents, antimicrobials, wound cleansers, and others are likely to get boost from their ongoing R&D activities, in turn estimating highest number of new product launches in the near future. The wound closure agents segment is anticipated to lose its market share during the forecast period, and is expected to hold a share of 24.0% by 2025 from 28.1% in 2016. Availability of other advanced wound healing products with reduced risk of infection are factors likely to hamper the market share of this segment.
Key Players such as Acelity L.P., Inc., Smith & Nephew plc, and Mölnlycke Health Care AB are Likely to Continue to Lead the Global Wound Healing Market
The report also provide profiles of leading players operating in global wound healing market include Smith & Nephew plc, Integra LifeSciences Corporation, B. Braun Melsungen AG, Mölnlycke Health Care AB, 3M Healthcare, Ethicon, Inc. (Johnson & Johnson), Hill-Rom Holdings, Inc., Cardinal Health, Acelity L.P., Inc., ConvaTec Inc., BSN medical (Svenska Cellulosa Aktiebolaget SCA), Coloplast Group, Medline Industries, Inc., Organogenesis Inc., and Hollister Incorporated. Expansion of wound healing portfolio by acquiring the wound healing platform of emerging players is a key strategy adopted by many key players.
Posted by at No comments:

Vaccines Market by Technology Advancement and Future Outlook 2017 - 2025

According to the experts at Transparency Market Research, the global vaccines market is expected to grow with a CAGR of 6.0% in the forecast period of 2017 to 2025. They also predict that the market is projected to worth US$48.0 bn by the end of 2025. It is noticeable that during the quarter of 2016, the market stood at US$28.0 bn.
Based on the indication of the disease, meningococcal segment is expected to exhibit maximum growth in the global vaccines market. The growth of the segment is attributed to rising government investments in meningococcal vaccination programs. Also, high prevalence of meningococcal diseases in various regions of the world is also supporting the growth of the segment in the global vaccines market.
Geographically, the global vaccines market has its presence across various regions such as North America, Asia Pacific, South America, and Middle East and Africa. Out of these regions, North America is expected to register highest CAGR in the forecast period. The maximum growth in the region can be attributed to the major research and development based investments by key players in the region and occurrence of major technological advancements in healthcare sector too.
Vaccines for Kids to Propel the Growth of Global Vaccines Market
The global vaccines market caters to the vaccination requirement for masses of all age groups. It also accounts for a huge share of vaccination for children. The dire need of children vaccines to prevent them from serious diseases is expected to propel the growth of global vaccines market. Also, multiple technological advancements in healthcare sector and various hospitals is expected to support the growth of global vaccines market during the projected duration.
Secondly, high prevalence of infectious diseases along with a growing focus on multiple immunization programs are expected to enhance the growth of global vaccines market in coming years. Factors such as rising support by the governments of various countries along with the accelerated reimbursement policies, demand for better healthcare solutions, and various research in order to develop vaccines for numerous diseases are expected to be key parameters promoting the growth of the global vaccines market during the forecast period of 2017 to 2026.
Finally, growth in the use of adjuvants in vaccines and major focus of therapeutic vaccines are expected to promote the growth of global vaccines market and offer maximum potential to the players in coming years.
High Cost of Vaccine Development to Damp the Growth
Development of vaccines requires intense research and development along with a huge amount of resources and data. All of these things makes vaccines development costlier for the manufacturers. Due the high cost involved in the production of vaccines, the growth of global vaccines market may get hampered to some extent in the forecast period. However, the increase in the number of distribution channel, and rising popularity of institutional sales is expected to help the global vaccines market maintain its momentum and grow substantially in the forecast period.
Transparency Market Research’s latest report provides an in-depth analysis of global vaccines market. It enlightens various facets of the highly fragmented global vaccines market and provides actionable insights to various businesses. According to the report, the market is dominated by the presence of prominent players. In order to maintain their dominance in the global vaccines market, key players are investing heavily on research and development activities along with various other notable developments. Over the period of time these players have adopted strategies such as mergers and acquisitions which is expected to promote the competitive environment of the market in the forecast period of 2017 to 2025.
Some of the key players of global vaccines market are Mitsubishi Tanabe Pharma Corporation, Janssen Pharmaceutical Company, Sanofi Pasteur SA, GlaxoSmithKline plc, Emergent BioSolutions Inc., and Novavax AB.
Posted by at No comments:

Hearing Aids Market Global Market Size, Growth, Trends and 2024 Forecast Report

The global hearing aids market depicts a largely oligopolistic vendor landscape, notices Transparency Market Research (TMR). The presence of only six players makes the market’s competitive landscape fiercely consolidated. Although, the level of competition is extremely high in the global hearing aids market as these countable number of players are competing among themselves. The names of these leading six players include Sonova Holding AG, Starkey, Siemens Healthcare, Widex A/S, the William Demant Holding Group., and GN ReSound.
These dominant six players hold nearly 98% of the overall market share. Therefore, the possibility of the entry of new players in the global hearing aids market has become fairly difficult. Additionally, new players are facing difficulties in terms of extremely high initial investments, which appears as a key requirement in order to enroot themselves in the global hearing aids market. However, the leading players are engaging in core research for developing high-quality products for the customers. Moreover, they are acquiring advanced technologies and incorporating it with their existing products for better offerings.
Get PDF Brochure for Research Insights at
TMR’s experts’ projection reveals that the global hearing aids market will expand at a promising 4.5% CAGR during the assessment period from 2016-2024. The market was valued US$4.7 bn in 2015, and is expected to gain valuation of US$7bn by 2024-end.
From the perspective of end-users, the adult hearing aids segment is dominating over the pediatric hearing aids segment on account of capturing a total market share of approximately 95%. On the regional front, Europe showcases the maximum share in the global hearing aids market as the region has witnessed a consistent upgradation of medical technology.
Request a Sample of Report at 
Rapid Technological Advancements in Healthcare to Propel Growth
With the help of hearing technology, several advanced hearing aids have launched in the market with enhanced functionality and smart features. The factors highly responsible for fueling growth in the global hearing aids market include rising global adoption of hearing devices and increasing awareness regarding technologically advanced machines to treat deafness. Along with this, another major factor stimulates growth in the global hearing aids market is rising prevalence of hearing loss on account of growing burgeoning population.
Request For Discount On This Report – 
Governments in both developing and developed economies are highly emphasizing on early screening process of deafness. This factor is also propelling expansion in the global hearing aids market. Besides this, education and raised awareness about health among younger as well as adult population are also playing a crucial role in elevating demand for these hearing devices and other diagnostic services, which in turn is complementing the growth of the global hearing aids market.
Furthermore, a recent trend in using lithium-ion batteries inside the hearing aid devices is gaining traction. This is because of the batteries possess a long-lasting capacity. However, several other factors triggering the growth of the global hearing aids market include rising noise pollution worldwide and medical issues such as syphilis or rubella infections, which lead to congenital hearing loss.
Poor Healthcare Infrastructure in Emerging Economies to Obstruct Growth
Several developing countries are still far from achieving prominence within the healthcare industry. Thus, these countries are facing difficulties in providing hearing aids to the all the patients, which clearly hampering the growth of the global hearing aids market. Additionally, regular battery replacements and repairing hearing machinery are major challenges in the global hearing aids market. Nonetheless, various market players are making their efforts to offer advanced, durable products at low prices, which is expected to underpin the growth momentum of the global hearing aids market in the forthcoming years.
The review is based on a market research report by TMR, titled, “Hearing Aids Market (Product Type – Hearing Aids (Behind the Ear (BTE), Receiver in the Ear (RITE), In the Ear (ITE), Canal Hearing Aids (ITC), (CIC), & (IIC)), Bone Anchored Hearing Aids (BAHA); End-user (Pediatric, Adult)) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024”.
Posted by at No comments:
Subscribe to: Posts (Atom)